EPS HEALTH TECH (03860) announced that the Group is expected to record a loss of approximately HK$3 million for the six months ending September 30, 2025 (the Period), compared to a profit of about HK$17.1 million for the same period ending September 30, 2024. The projected loss is primarily attributed to (i) a decrease in fair value gains from acceptance notes related to non-controlling interests, and (ii) reduced government subsidies during the Period.